|
|
Volumn 7, Issue 5, 1998, Pages 761-783
|
|
Therapeutic advances of new fluoroquinolones
a
|
|
Author keywords
Clinical efficacy; Fluoroquinolones; Phases of development; Tolerability
|
|
Indexed keywords
AMINOGLYCOSIDE;
AMOXICILLIN;
BALOFLOXACIN;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CINOXACIN;
CIPROFLOXACIN;
CLARITHROMYCIN;
CLINAFLOXACIN;
ENOXACIN;
FLEROXACIN;
GATIFLOXACIN;
GLYCOPEPTIDE;
GREPAFLOXACIN;
LEVOFLOXACIN;
LOMEFLOXACIN;
MOXIFLOXACIN;
OFLOXACIN;
OXOLINIC ACID;
PENICILLIN G;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
ROSOXACIN;
SPARFLOXACIN;
TEMAFLOXACIN;
TETRACYCLINE DERIVATIVE;
TOSUFLOXACIN;
TROVAFLOXACIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ENTEROBACTERIACEAE;
HUMAN;
NONHUMAN;
REVIEW;
STREPTOCOCCUS PNEUMONIAE;
|
|
EID: 0031946231
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.7.5.761 Document Type: Review |
|
Times cited : (65)
|
|
References (140)
|
